The Proof with Simon Hill cover image

Cholesterol, metabolic health and heart disease | Dr Alan Flanagan and Danny Lennon

The Proof with Simon Hill

00:00

LP a Little Layer

LP looks like it's probably going to be declared the kind of the second causal biomarker for atherosclerotic cardiovascular disease. The previous interventions that have all been on the major LDL lowering drugs that we have really don't directly target LP a little A. It seems to be primarily driven by genetics. There's very little evidence that we have that diet that makes a kind of a meaningful difference to LP little A.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app